Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

GlaxoSmithKline Recalling Alli After Other Pills Found in Bottles

By Associated Press - Mar 27, 2014 at 10:38AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is asking pharmacies and retailers in the United States and Puerto Rico to immediately remove the drug from store shelves.

GlaxoSmithKline is recalling the weight loss drug Alli after receiving reports that other pills and tablets are being found in the bottles.

The over-the-counter drug comes in a turquoise blue capsule with a dark blue band and the text "60 Orlistat." However, consumers have been finding a range of tablets in the bottles, the British drugmaker said Thursday,

GlaxoSmithKline also says some bottles have tamper-resistant seals that are not authentic. Alli comes in bottles with an inner foil barrier labeled "Sealed for Your Protection."

Some of those bottles are missing labels.

The company is asking pharmacies and retailers in the United States and Puerto Rico to immediately remove the drug from store shelves.

link

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
652%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/09/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.